Gamma Knife Devices Market

Market Insights

The 2017 American Brain Tumor Association report cites that cancer is the second-leading cause of death globally, responsible for the deaths of approximately 8.8 million patients. The World Health Organization predicts the growth of cancer incidence to reach 70% in the next 20 years. Gamma knife devices face stringent market competition from other types of radiosurgery, such as linear accelerator systems (LINAC) and cyclotrons. They have meritorious features in comparison to the gamma knife in treating larger tumors in larger areas of the brain and other body parts and precisely targeting only the tumor cells, causing the least harm to the surrounding healthy cells.

Gamma knife devices are employed for cancer treatment for indications such as benign tumors, malignant tumors, functional disorders, vascular disorders, and ocular diseases. Through market estimation and data forecast, the performance of gamma knife devices as a therapy for the indication segment is elucidated.The geographical segment for gamma knife devices includes the country-level cross-sectional market estimation and data forecasting for 2015-2025.

Technological evolutions in the gamma knife devices, such as the radiation doses utilized, composite isocenters, and automated shielding for enhanced device safety and accuracy, are studied in the company profiles section. The latest mergers and acquisitions among the premier players are mentioned in recent news coverage. The competitive landscape gives information about the existing monopoly in gamma knife devices, e.g., Elekta AB, and ambitious business tactics applied by other major players to capture the market. The foremost leaders in the development of gamma knife devices for cancer treatment are Elekta AB, American Shared Hospital Services, Hokai, Cyber Medical Corporation Limited, ET Medical Group, Huiheng Medical, Inc., Masep Infini Global, Inc., Nordion, Inc., and Varian Medical Systems, Inc.

According to indications, the gamma knife devices market is classified as follows:

• Benign Tumors
• Malignant Tumors
• Functional Disorders
• Vascular Disorders
• Ocular Diseases

Gamma knife is a radiation surgery therapy employed for the treatment of brain tumors, epilepsy, arteriovenous malformations, and trigeminal neuralgia. The procedure consists of delivering finely focused radiation of a high dose to the target cells, and its high degree of precision and accuracy prevents damage to the surrounding healthy cells. It is used for the treatment of abnormalities measuring 1 inch in diameter.

Malignant tumors have a big market in the indications segment as a result of the rising prevalence of patients suffering from malignant cancers. Additionally, gamma knife therapy finds huge application in the treatment of malignant tumors owing to its safety features and accuracy. Fractionated external radiation therapy is considered an adjuvant therapy for the treatment of primary brain tumors. Teletherapy, a kind of gamma knife radiosurgery, is finding huge attraction for the treatment of ocular diseases such as choroidal melanoma and uveal melanoma.

Low-radiation gamma therapy is also utilized to reduce intraocular pressure for the treatment of glaucoma. The chief players in the global gamma knife devices market are American Shared Hospital Services, Cyber Medical Corporation Limited, ET Medical Group, Elekta AB, Hokai, Huiheng Medical, Inc., Masep Infini Global, Inc., Nordion, Inc., and Varian Medical Systems, Inc.

For the purpose of this study, the global market for gamma knife devices is categorized into the following regional and country-specific markets:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • France
  • Italy
  • U.K.
  • Russia
  • Rest of Europe
• Asia-Pacific
  • India
  • China
  • Japan
  • Rest of Asia-Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East and Africa
  • GCC Countries
  • South Africa
  • Rest of Middle East and Africa

According to the Centers for Disease Control and Prevention’s 2014 survey research findings, there are approximately 1.5 million cases of invasive cancer each year, with approximately 590,000 people dying as a result of cancer. The rising prevalence of cancer and increasing demand for non-invasive radiation therapy drive the gamma knife device market in North America. Western Europe is a rapidly expanding market due to the presence of key players who pioneered the production of gamma knife devices. Additionally, the effective cancer treatment guidelines formulated by the EU have favored radiation therapy as adjuvant therapy for the treatment of cancer, which adds to the market growth in Europe. Asia Pacific dominates the gamma knife devices market on account of the rising prevalence of brain tumors and the increasing number of specialty clinics providing effective cancer diagnosis and treatment. Japan has invested heavily in the research and development of radiation therapy devices utilized for cancer treatment.

Chapter 1. Preface
1.1. Report Scope and Description
1.2. Research Methodology
1.2.1. Phase I-Secondary Research
1.2.2. Phase II-Primary Research
1.2.3. Phase III-Expert Panel Review
1.2.4. Assumptions
1.2.5. Approach Adopted

Chapter 2. Executive Summary
2.1. Global Gamma Knife Devices Market Portraiture
2.1.1. Global Gamma Knife Devices Market, by Indications, 2016 (Value %)
2.1.2. Global Gamma Knife Devices Market, by Geography, 2016 (Value %)

Chapter 3. Gamma Knife Devices Market: Dynamics and Future Outlook
3.1. Market Overview
3.2. Drivers
3.3. Challenges
3.4. Opportunities
3.5. Attractive Investment Proposition, by Geography
3.6. Top 3 Countries: Global Gamma Knife Devices Market, 2015-2025 (US$ Mn)
3.7. Competitive Landscape: Global Gamma Knife Devices Market, by Key Players, 2015-2025 (US$ Mn)

Chapter 4. Global Gamma Knife Devices Market, by Indications, 2015 – 2025 (US$ Mn)
4.1. Overview
4.2. Attractive Investment Proposition: Global Gamma Knife Devices Market, by Indications, 2016
4.3. Benign Tumors
4.4. Malignant Tumors
4.5. Functional Disorders
4.6. Vascular Disorders
4.7. Ocular Diseases

Chapter 5. Global Gamma Knife Devices Market, by Geography, 2015 – 2025 (US$ Mn)
5.1. Overview
5.2. North America Gamma Knife Devices Market Analysis, 2015 – 2025
5.2.1. North America Gamma Knife Devices Market, by Indications, 2015 – 2025 (US$ Mn)
5.2.2. North America Gamma Knife Devices Market, by Country, 2015 – 2025 (US$ Mn)
5.2.2.1. U.S.
5.2.2.1.1. U.S. Gamma Knife Devices Market, by Indications, 2015-2025 (US$ Mn)
5.2.2.2. Canada
5.2.2.2.1. Canada Gamma Knife Devices Market, by Indications, 2015-2025 (US$ Mn)
5.3. Europe Gamma Knife Devices Market Analysis, 2015 – 2025
5.3.1. Europe Gamma Knife Devices Market, by Indications, 2015 – 2025 (US$ Mn)
5.3.2. Europe Gamma Knife Devices Market, by Country, 2015 – 2025 (US$ Mn)
5.3.2.1. U.K.
5.3.2.1.1. U.K. Gamma Knife Devices Market, by Indications, 2015-2025 (US$ Mn)
5.3.2.2. Germany
5.3.2.2.1. Germany Gamma Knife Devices Market, by Indications, 2015-2025 (US$ Mn)
5.3.2.3. Rest of Europe
5.3.2.3.1. Rest Of Europe Gamma Knife Devices Market, by Indications, 2015-2025 (US$ Mn)
5.4. Asia Pacific Gamma Knife Devices Market Analysis, 2015 – 2025
5.4.1. Asia Pacific Gamma Knife Devices Market, by Indications, 2015 – 2025 (US$ Mn)
5.4.2. Asia Pacific Gamma Knife Devices Market, by Country, 2015 – 2025 (US$ Mn)
5.4.2.1. Japan
5.4.2.1.1. Japan Gamma Knife Devices Market, by Indications, 2015-2025 (US$ Mn)
5.4.2.2. China
5.4.2.2.1. China Gamma Knife Devices Market, by Indications, 2015-2025 (US$ Mn)
5.4.2.2.2. India Gamma Knife Devices Market, by Indications, 2015-2025 (US$ Mn)
5.4.2.3. Rest of Asia Pacific
5.4.2.3.1. Rest Of Asia Pacific Gamma Knife Devices Market, by Indications, 2015-2025 (US$ Mn)
5.5. Latin America Gamma Knife Devices Market Analysis, 2015 – 2025
5.5.1. Latin America Gamma Knife Devices Market, by Indications, 2015 – 2025 (US$ Mn)
5.5.2. Latin America Gamma Knife Devices Market, by Country, 2015 – 2025 (US$ Mn)
5.5.2.1. Brazil
5.5.2.1.1. Brazil Gamma Knife Devices Market, by Indications, 2015-2025 (US$ Mn)
5.5.2.2. Mexico
5.5.2.2.1. Mexico Gamma Knife Devices Market, by Indications, 2015-2025 (US$ Mn)
5.5.2.3. Rest of Latin America
5.5.2.3.1. Rest Of Latin America Gamma Knife Devices Market, by Indications, 2015-2025 (US$ Mn)
5.6. Middle East & Africa Gamma Knife Devices Market Analysis, 2015 – 2025
5.6.1. Middle East and Africa Gamma Knife Devices Market, by Indications, 2015 – 2025 (US$ Mn)
5.6.2. Middle East and Africa Gamma Knife Devices Market, by Region, 2015 – 2025 (US$ Mn)
5.6.2.1. GCC
5.6.2.1.1. GCC Gamma Knife Devices Market, by Indications, 2015-2025 (US$ Mn)
5.6.2.2. Rest of Middle East and Africa
5.6.2.2.1. Rest Of Middle East and Africa Gamma Knife Devices Market, by Indications, 2015-2025 (US$ Mn)

Chapter 6. Company Profiles
6.1. American Shared Hospital Services
6.1.1. Business Description
6.1.2. Financial Information (Subject to data availability)
6.1.3. Product Portfolio
6.1.4. Key Developments
6.2. Cyber Medical Corporation Limited
6.3. ET Medical Group
6.4. Elekta AB
6.5. Hokai
6.6. Huiheng Medical, Inc.
6.7. Masep Infini Global, Inc.
6.8. Nordion, Inc.
6.9. Varian Medical Systems, Inc.

List of Figures

FIG. 1 Gamma Knife Devices: Market Segmentation
FIG. 2 Global Gamma Knife Devices Market Share, by Indications, 2016 (Value %)
FIG. 3 Global Gamma Knife Devices Market Share, by Geography, 2016 (Value %)
FIG. 4 Attractive Investment Proposition, by Geography
FIG. 5 Market Competition Landscape, by Key Players, 2016
FIG. 6 Global Benign Tumors Market for Gamma Knife Devices, 2015 – 2025 (US$ Mn)
FIG. 7 Global Malignant Tumors Market for Gamma Knife Devices, 2015 – 2025 (US$ Mn)
FIG. 8 Global Functional Disorders Market for Gamma Knife Devices, 2015 – 2025 (US$ Mn)
FIG. 9 Global Vascular Disorders Market for Gamma Knife Devices, 2015 – 2025 (US$ Mn)
FIG. 10 Global Ocular Diseases Market for Gamma Knife Devices, 2015 – 2025 (US$ Mn)

List of Tables

TABLE 1 Global Gamma Knife Devices Market Portraiture
TABLE 2 Global Gamma Knife Devices Market, by Indications, 2015 – 2025 (US$ Mn)
TABLE 3 Global Gamma Knife Devices Market, by Geography, 2015 – 2025 (US$ Mn)
TABLE 4 North America Gamma Knife Devices Market, by Indications, 2015 – 2025 (US$ Mn)
TABLE 5 North America Gamma Knife Devices Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 6 U.S. Gamma Knife Devices Market, by Indications, 2015 – 2025 (US$ Mn)
TABLE 7 Canada Gamma Knife Devices Market, by Indications, 2015 – 2025 (US$ Mn)
TABLE 8 Europe Gamma Knife Devices Market, by Indications, 2015 – 2025 (US$ Mn)
TABLE 9 Europe Gamma Knife Devices Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 10 U.K. Gamma Knife Devices Market, by Indications, 2015 – 2025 (US$ Mn)
TABLE 11 Germany Gamma Knife Devices Market, by Indications, 2015 – 2025 (US$ Mn)
TABLE 12 Rest of Europe Gamma Knife Devices Market, by Indications, 2015 – 2025 (US$ Mn)
TABLE 13 Asia Pacific Gamma Knife Devices Market, by Indications, 2015 – 2025 (US$ Mn)
TABLE 14 Asia Pacific Gamma Knife Devices Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 15 Japan Gamma Knife Devices Market, by Indications, 2015 – 2025 (US$ Mn)
TABLE 16 China Gamma Knife Devices Market, by Indications, 2015 – 2025 (US$ Mn)
TABLE 17 India Gamma Knife Devices Market, by Indications, 2015 – 2025 (US$ Mn)
TABLE 18 Rest of Asia Pacific Gamma Knife Devices Market, by Indications, 2015 – 2025 (US$ Mn)
TABLE 19 Latin America Gamma Knife Devices Market, by Indications, 2015 – 2025 (US$ Mn)
TABLE 20 Latin America Gamma Knife Devices Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 21 Brazil Gamma Knife Devices Market, by Indications, 2015 – 2025 (US$ Mn)
TABLE 22 Mexico Gamma Knife Devices Market, by Indications, 2015 – 2025 (US$ Mn)
TABLE 23 Rest of Latin America Gamma Knife Devices Market, by Indications, 2015 – 2025 (US$ Mn)
TABLE 24 Middle East And Africa Gamma Knife Devices Market, by Indications, 2015 – 2025 (US$ Mn)
TABLE 25 Middle East And Africa Gamma Knife Devices Market, by Region, 2015 – 2025 (US$ Mn)
TABLE 26 GCC Gamma Knife Devices Market, by Indications, 2015 – 2025 (US$ Mn)
TABLE 27 Rest of Middle East and Africa Gamma Knife Devices Market, by Indications, 2015 – 2025 (US$ Mn)
TABLE 28 American Shared Hospital Services: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 29 Cyber Medical Corporation Limited: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 30 ET Medical Group: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 31 Elekta AB: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 32 Hokai: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 33 Huiheng Medical, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 34 Masep Infini Global, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 35 Nordion, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 36 Varian Medical Systems, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)